Overview
Status
Active
Registry date
2021-12-30
Share capital
50,000.00 PLN
Registered address
ul. Pojezierska 97K, 91-341 Łódź, Poland
Electronic delivery address
AE:PL-49931-71910-BAESU-18
Financials
Revenue history (in k)
Filing timeliness
1 of 4 financial statements was filed late (for 2025, 2 days late).
- 202517/07/2026
- 202411/07/2025
- 202327/05/2024
- 202206/07/2023
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 186.92kMedianUSD 55.24kAverageUSD 2.70m
Net profit
This companyUSD 286.03MedianUSD -1.27kAverageUSD -92.18k
Operating costs
This companyUSD 186.60kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 74.60kMedianUSD 133.19kAverageUSD 3.03m
Industry
Trademarks
Labpoint holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2021.
| Mark | Protected until | |
|---|---|---|
| LABPOINT | Nov 23, 2031 |
Authorized Representatives
Paulina Skalik
Manner of representation
The company may be represented by each member of the management board acting independently, or by a commercial proxy acting independently.
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Proteon PharmaceuticalsS.A. | $2,026,826.52 | proteonpharmaspolkaakcyjna.pl | ||
| Centrum Badań Weterynaryjnych Vetcomplexsp. z o.o. | $255,522.81 | vetcomplex.pl | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| VASA Therapeuticssp. z o.o. | $216,535.01 | vasatherapeutics.com | ||
| Phage Consultantssp. z o.o. | $193,130.82 | phageconsultants.com | ||
| Bactremsp. z o.o. | $181,958.36 | bactrem.pl | ||
| MultiqureS.A. | $149,394.35 | purebiologics.com | ||
| FcbiotechS.A. | $148,945.77 | fcbiotech.pl | ||
| UveraS.A. | $155,384.29 | uvera.eu | ||
| Luna Laboratorysp. z o.o. | $61,894.23 | lunalab.pl |
FAQ
The main business activity of Labpoint focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on December 30, 2021.
The headquarters is located at: ul. Pojezierska 97K, 91-341 Łódź.
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of $186,917 in 2025, which is a decrease of 14.5% compared to 2024.
Yes, in 2025 the company was profitable, achieving a net profit of $286, meaning the company decreased its profit by 99.5%.
The largest operating cost category falls under employee remuneration. This category amounted to $82,869 in 2025, representing 44% of all operating expenses.
Last updated: 2026-10-07
